Literature DB >> 22157214

Impact of neoadjuvant chemotherapy on physical fitness, physical activity, and health-related quality of life of patients with resectable esophageal cancer.

Noriatsu Tatematsu1, Yasumasa Ezoe, Eiji Tanaka, Manabu Muto, Yoshiharu Sakai, Tadao Tsuboyama.   

Abstract

OBJECTIVE: Neoadjuvant chemotherapy (NAC) followed by radical surgery is the standard treatment for patients with resectable esophageal squamous cell carcinoma (ESCC) in Japan. However, some adverse events associated with NAC may result in a decrease in physical fitness that may influence the patient's ability to tolerate surgery. The purpose of this study was to evaluate the impact of NAC on physical fitness, physical activity, and health-related quality of life (HRQOL) of patients with ESCC.
METHODS: In this prospective study, we investigated 27 consecutive patients with newly diagnosed resectable ESCC who were scheduled to receive NAC followed by surgery between January 2009 and November 2010. Primary endpoints were change from baseline in physical fitness (knee extensor muscle strength and 6-min walking distance) and physical activity after NAC. A secondary endpoint was change from baseline in HRQOL.
RESULTS: Physical fitness and physical activity level after NAC did not differ significantly from those before NAC. With regard to HRQOL, only social functioning was significantly different (P=0.04). The change in physical activity demonstrated a significant correlation with the change in 6-minute walking distance (r=0.45, P=0.02).
CONCLUSIONS: NAC had no impact on physical fitness and physical activity in patients with ESCC. This result indicated that there was no need for a physiotherapy intervention during NAC to prevent a decline in these parameters.

Entities:  

Mesh:

Year:  2013        PMID: 22157214     DOI: 10.1097/COC.0b013e3182354bf4

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Physical decline and its implications in the management of oesophageal and gastric cancer: a systematic review.

Authors:  Linda O'Neill; Jonathan Moran; Emer M Guinan; John V Reynolds; Juliette Hussey
Journal:  J Cancer Surviv       Date:  2018-05-23       Impact factor: 4.442

2.  RNA interference for epidermal growth factor receptor enhances the radiosensitivity of esophageal squamous cell carcinoma cell line Eca109.

Authors:  Heping Zhang; Jiancheng Li; Wenfang Cheng; D I Liu; Cheng Chen; Xiaoying Wang; Xujing Lu; Xifa Zhou
Journal:  Oncol Lett       Date:  2015-07-03       Impact factor: 2.967

3.  Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.

Authors:  Emer M Guinan; S L Doyle; A E Bennett; L O'Neill; J Gannon; J A Elliott; J O'Sullivan; J V Reynolds; J Hussey
Journal:  Support Care Cancer       Date:  2017-12-02       Impact factor: 3.603

4.  Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies.

Authors:  Mohsen Asadi-Lari; Fatemeh Homaee-Shandiz; Ali Esmaeili-Hesari
Journal:  Med J Islam Repub Iran       Date:  2018-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.